![Hans-Peter Gerber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 324 298 $ in data 30/06/2026
Hans-Peter Gerber currently works at T-CURX GmbH, as Chairman and Sutro Biopharma, Inc., as Chief Scientific Officer from 2023.
Dr. Gerber also formerly worked at NBE-Therapeutics AG, as Independent Director from 2017 to 2021 and Maverick Therapeutics, Inc., as President, Director & Chief Science Officer from 2016 to 2018.
Dr. Gerber received his graduate degree and doctorate degree from the University of Zurich.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 9.768 ( 0,06% ) | 324 298 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 18/09/2023 |
T-CURX GmbH
 T-CURX GmbH BiotechnologyHealth Technology Operates as a biotech company that develops immunotherapies to treat cancer | Presidente | - |
| Società | Posizione | Fine |
|---|---|---|
NBE-Therapeutics AG
 NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Direttore/Membro del Consiglio | 01/01/2021 |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Presidente | 01/01/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NBE-Therapeutics AG
NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Health Technology |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
T-CURX GmbH
T-CURX GmbH BiotechnologyHealth Technology Operates as a biotech company that develops immunotherapies to treat cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
